Package Leaflet: Information for theuser
Viaflo Sodium Chloride 0.9% solution for infusion
Active ingredient: sodium chloride
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
This medicine is called “Viaflo Sodium Chloride 0.9% solution for infusion”, but it will be referred to as Viaflo Sodium Chloride 0.9% throughout this leaflet.
Contents of the package leaflet:
Viaflo Sodium Chloride 0.9% is a solution of sodium chloride in water. Sodium chloride is a chemical substance (commonly called salt) that is found in the blood.
Viaflo Sodium Chloride 0.9% is used to treat:
The situations that can cause loss of water and sodium include:
Viaflo Sodium Chloride 0.9% can also be used to administer or dilute other medicines for infusion.
Viaflo Sodium Chloride 0.9% will not be given to you if you have any of the following medical conditions:
If another medicine has been added to Viaflo Sodium Chloride 0.9%, you should consult the package leaflet of that medicine to determine if you can receive the solution.
Warnings and precautions
Tell your doctor if you have or have had any of the following medical conditions:
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you are being given this solution, your doctor may take blood and urine samples to monitor:
This is especially important in children and babies (premature babies), as they may retain too much sodium due to their immature kidney function.
Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by infusion into a vein). During prolonged treatment with Viaflo Sodium Chloride 0.9%, you may need to be given extra nutrition.
Other medicines and Viaflo Sodium Chloride 0.9%
Tell your doctor or nurse if you are using, have recently used, or might use any other medicines.
It is especially important that you tell your doctor if you are taking:
These medicines can cause the body to retain sodium and water, leading to tissue inflammation due to fluid accumulation under the skin (edema) and high blood pressure (hypertension).
Using Viaflo Sodium Chloride 0.9% with food and drinks
Ask your doctor about what you can eat or drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse.
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Ask your doctor or nurse for advice before driving or using machines.
Viaflo Sodium Chloride 0.9% will be given to you by a doctor or nurse. Your doctor will decide how much you need and when you will be given it. This will depend on your age, weight, medical condition, the reason for your treatment, and whether the infusion is being used to administer or dilute another medicine.
The amount you receive may also be influenced by other treatments you are receiving.
Do not receive Viaflo Sodium Chloride 0.9% if there are particles floating in the solution or if the packaging is damaged in any way.
Viaflo Sodium Chloride 0.9% will usually be given to you through a plastic tube connected to a needle in a vein, usually in your arm. However, your doctor may use another method to give you the medicine.
Before and during the infusion, your doctor will monitor:
Any unused solution should be discarded. You should not receive Viaflo Sodium Chloride 0.9% from a partially used bag.
If you receive more Viaflo Sodium Chloride 0.9% than you should
If you are given too much Viaflo Sodium Chloride 0.9% (overdose), the following symptoms may occur:
If you notice any of these symptoms, you should tell your doctor immediately. Your infusion will be stopped and you will be treated depending on the symptoms.
If another medicine has been added to Viaflo Sodium Chloride 0.9% before the overdose, that medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
If you stop receiving Viaflo Sodium Chloride 0.9%
Your doctor will decide if you should stop receiving this infusion.
If you have any further questions about the use of this product, ask your doctor or nurse.
In case of overdose or accidental ingestion, contact the Toxicology Information Service. Telephone 915.620.420
Like all medicines, this medicine can cause side effects, although not everybody gets them. The frequency of these effects is unknown.
Low sodium levels in the blood that can be acquired during hospitalization (hospital-acquired hyponatremia) and related neurological disorder (acute hyponatremic encephalopathy).
Side effects that may occur due to the administration technique include:
Other side effects that have been reported with similar products (other solutions containing sodium) include:
Reporting side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's online platform: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
If any of these occur, the infusion should be stopped.
Keep this medicine out of the sight and reach of children.
Bags of 50 and 100 ml: Do not store above 30°C.
Bags of 250, 500, and 1000 ml: No special storage conditions are required.
Do not use this medicine after the expiry date which is stated on the bag after EXP. The expiry date is the last day of the month shown.
Do not receive this medicine if there are particles floating in the solution or if the packaging is damaged in any way.
Composition ofViaflo Sodium Chloride 0.9%
The active ingredient is sodium chloride: 9 g per liter.
The only excipient is water for injectable preparations.
Appearance of the Product and Container Contents
Viaflo Sodium Chloride 0.9% is a clear solution, free from visible particles. It is presented in polyolefin/polyamide plastic bags (Viaflo). Each bag is packaged in a sealed protective overbag.
The bag sizes are:
The presentations are:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Holder
Baxter S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Manufacturer:
Baxter S.A.
Boulevard René Branquart, 80
7860 Lessines
Belgium
Bieffe Medital S.A.
Ctra. de Biescas, Senegüé
22666 Sabiñanigo (Huesca)
Spain
Vantive Manufacturing Limited
Moneen Road
Castlebar
County Mayo
Ireland
Bieffe Medital S.p.A
Via Nuova Provinciale
23034 Grosotto (SO)
Italy
Date of the Last Revision of thisProspectus: October 2023
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for healthcare professionals
Handling and Preparation
Use only if the solution is clear, free from visible particles, and the container is intact. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the sterility of the solution.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air dragged from the primary container before the administration of the liquid contained in the secondary container is completed.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can lead to a gas embolism if the residual air in the container is not fully evacuated before administration.
The solution must be administered with sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air from entering the system.
When adding medications, verify isotonicity before parenteral administration. A complete and careful aseptic mixture of any medication is necessary. Solutions containing medications should be used immediately and not stored.
The addition of other medications or the use of an incorrect administration technique can cause the appearance of febrile reactions due to the possible introduction of pyrogens. In the event of an adverse reaction, the infusion should be interrupted immediately.
Discard after a single use.
Discard any remaining portion.
Do not reconnect partially used bags.
1- To Open
2- Preparation for Administration
Use sterile material for preparation and administration.
3- Techniques for Injecting Added Medication
Warning: Added medications may be incompatible. (See section 5 "Incompatibilities of Added Medications" below)
To Add Medication Before Administration
Precaution: Do not store bags with added medication.
To Add Medication During Administration
Before use, the physical and chemical stability of any added medication must be established at the pH of the Viaflo Sodium Chloride 0.9% solution in the Viaflo bag.
From a microbiological point of view, the diluted product must be used immediately unless the addition of medications has been carried out under aseptic and validated conditions. If it is not used immediately, the conditions and storage times used before its use are the responsibility of the user.
5- Incompatibilities of Added Medications
As with all parenteral solutions, the incompatibility of medications added to the solution in the Viaflo bag must be verified before addition.
In the absence of compatibility studies, this solution should not be mixed with other medications.
It is the responsibility of the physician to judge the incompatibility of the added medication to Viaflo Sodium Chloride 0.9% by examining any eventual color change and/or precipitation, appearance of insoluble complexes or crystals. The prospectus of the medication to be added should be consulted.
Before adding a medication, verify that it is soluble and stable in water at the pH of Viaflo Sodium Chloride 0.9%.
Medications known to be incompatible should not be used.